The stock decreased 0.51% or $0.74 during the last trading session ... It also reduced its holding in Hologic Inc …
The stock has a market cap of 22.28 billion and a long-term expected earnings growth rate of 10.40%. Currently, Bard carries a Zacks Rank #3 (Hold). Let us take a look at the key catalysts driving the stock’s ... Inc. HOLX and Sunshine …
Recently, Hologic Inc. ( HOLX), a prominent player in the women's healthcare market, gained the U.S. Food and Drug Administration (FDA) clearance for the commercial launch of its Aptima Trichomonas vaginalis Assay to be used on its …
Hologic Inc (NASDAQ:HOLX) traded in a range yesterday that spanned from a low of $37.03 to a high of $38.20. Yesterday, the shares gained 3.5%, which took the trading range above the 3-day high of $38.06 on volume of 1.4 …
Hologic (NASDAQ: HOLX) is up more than three percent in after hours trading after the company announced its first quarter results. The firm reported a Q1 EPS of $0.34 versus the Street estimate of $0.31. Revenue was down three percent …
Jan 16 (Reuters) - Hologic Inc ::HOLOGIC ANNOUNCES PRICING OF OFFERING OF $1 BILLION OF SENIOR NOTES.PRICED ‍$600 MILLION AGGREGATE PRINCIPAL AMOUNT OF ADDITIONAL 4.375% SENIOR NOTES DUE …
Hologic Inc. HOLX reported second-quarter fiscal 2017 adjusted earnings per share (EPS) of 50 cents, up 6.4% year over year. Adjusted EPS also beat the Zacks Consensus Estimate of 46 cents and exceeded the company’s guidance of …
The company reported better-than-expected fourth-quarter fiscal 2014 results with adjusted earnings per share (EPS) and revenues exceeding the respective Zacks Consensus Estimate. Notably, this marks the company's first quarter wherein …
Hologic Inc (NASDAQ:HOLX) traded in a range yesterday that spanned from a low of $35.10 to a high of $37.71. Yesterday, the shares fell 10.4%, which took the trading range below the 3-day low of $38.59 on volume of 5.3 million …